Miriam Provost is VP at TransMedics Group, Inc. (TMDX). They have made 5 open-market trades across 1 company since 2021, most recently 2023-12-15.
CIK 0001773663
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TMDX | 23,943 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2023-12-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TMDX | SELL | 2023-12-13 | 2023-12-15 | $75.10 | $604K | +4.4% | +2.1% | +1.5% |
| TMDX | SELL | 2023-08-31 | 2023-09-05 | $66.52 | $360K | -7.3% | -20.5% | +16.3% |
| TMDX | SELL | 2022-12-13 | 2022-12-15 | $62.42 | $438K | +0.2% | +9.8% | +27.3% |
| TMDX | SELL | 2022-12-09 | 2022-12-13 | $59.00 | $213K | -2.2% | -1.9% | +20.1% |
| TMDX | SELL | 2021-09-15 | 2021-09-17 | $31.34 | $243K | +4.5% | -13.4% | -32.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.